Condition: Facial Dryness · Facial Dullness · Sponsor: IBSA Farmaceutici Italia Srl
The aim of the study is to evaluate the safety and efficacy of sodium hyaluronate 32 mg/ml in improving facial skin dryness and dullness. Subjects are randomized to the treatment group or to the control group. Only subjects in the treatment group are treated by intradermal injection.
This description comes directly from the study's public registry record.
Yan Wu, Professor · 13910978643 · 3437477565@qq.com
Always discuss trial participation with your own doctor first.
| Peking Union Medical College Hospital (PUMCH) | Beijing, China | Recruiting |
| Peking University First Hospital | Beijing, China | Recruiting |
| The First Principle Hospital of Changde City | Changde, China | Recruiting |
| West China Hospital of Stomatology Sichuan Hospital | Chengdu, China | Recruiting |
| Tongji Hospital of Tongji University | Shanghai, China | Not Yet Recruiting |
| The Second Affiliated Hospital Of Xi'an Jiaotong University | Xi'an, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06914583